Albert Grinshpun, Amir Sonnenblick, Yasmin Leshem, Salome Khutsurauli, Nil Fridman, Areen Abu Remilah, Shani Breuer, Ora Solange Rosengarten, Daniela Katz. "A phase II study evaluating treatment discontinuation of dual anti-HER2 therapy in metastatic HER2-positive breast cancer after five years of sustained complete response (FREEDOME-trial).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps1143